ImmunoACT to lead journey of indigenous CAR-T cell therapy in India but market access a hurdle:…
As per ImmunoACT CEO, NexCAR19 will be available at a price of Rs 30-40 lakh ($36,000- $48,000), which is 1/10th of the cost of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CAR-T
Cell therapy for solid tumors may get approval by 2022: GlobalData
A total of 298 industry-sponsored trials are currently ongoing investigating cell therapies in non-haematological cancers, says…